Drugmakers brace for generic versions of biotech blockbusters
Friday, May 27, 2011 - 13:00
in Mathematics & Economics
In 2001, Abbott Laboratories spent nearly $7 billion on the biggest acquisition in the company's 123-year history, primarily to access one drug, Humira.
